CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CinCor Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Why These Two Biotech Stocks Blasted Higher This Week ↗

January 13, 2023

There's nothing like a big-premium buyout to send a company's share price to the moon.

Via The Motley Fool

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

Where CinCor Pharma Stands With Analysts ↗

January 12, 2023

Via Benzinga

AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout ↗

January 10, 2023

CinCor will bolster AstraZeneca's growing cardio-renal business.

Via Investor's Business Daily

S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher ↗

January 09, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday.

Via Benzinga

Where CinCor Pharma Stands With Analysts ↗

December 07, 2022

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 09, 2023

Via Benzinga

Stocks Building Off Of Friday's Rally ↗

January 09, 2023

The Dow Jones Industrial Average is up more than 280 points midday, while the Nasdaq Composite Index is also up triple digits.

Via Talk Markets

Nasdaq Surges Over 200 Points; Crude Oil Rises 2% ↗

January 09, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.

Via Benzinga

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal ↗

January 09, 2023

AstraZeneca stock wavered as it agreed to buy CinCor Pharma, maker of blood pressure drug baxdrostat for $1.8 billion. CINC stock soared.

Via Investor's Business Daily

Why Is CinCor (CINC) Stock Up 138% Today? ↗

January 09, 2023

CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion.

Via InvestorPlace

Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday ↗

January 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Open Higher; Dow Rises 150 Points ↗

January 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗

January 09, 2023

Bloomberg

Via Benzinga

AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline ↗

January 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 09, 2023

Via Benzinga

Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 09, 2023

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Analyzing CinCor Pharma's Short Interest ↗

January 03, 2023

CinCor Pharma's (NASDAQ:CINC) short percent of float has risen 4.28% since its last report. The company recently reported that it has 2.25 million shares sold short, which is 8.78% of all regular...

Via Benzinga

Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday ↗

November 29, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

On Friday, 72 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 29, 2022

Via Benzinga

Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session ↗

November 29, 2022

Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share.

Via Benzinga

US Stocks Edge Higher Following Monday's Sell-Off ↗

November 29, 2022

U.S. stocks traded slightly higher this morning, with the Dow Jones gaining more than 30 points on Tuesday. The blue-chip index dropped around 500 points on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 ↗

November 29, 2022

Via Benzinga

FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday ↗

November 29, 2022

Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...

Via Benzinga

Dow Tumbles 450 Points; S&P 500 Falls 1.5% ↗

November 28, 2022

U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.

Via Benzinga

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 28, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.